

Publisher: Bentham Science Publishers
E-ISSN: 1875-5453|14|3|361-365
ISSN: 1389-2002
Source: Current Drug Metabolism, Vol.14, Iss.3, 2013-03, pp. : 361-365
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
The interactions between disease processes and the metabolism of therapeutic drugs have not been systematically investigated. Inflammation, with the presence of pro-inflammatory cytokines, affects Phase 1 metabolism, particularly the activity of the CYP isoforms. Inflammatory factors also alter the activity of some Phase 2 enzymes, particularly the sulphotransferases (SULT isoforms) responsible for drug sulphonation and the enzyme pathway involved in the supply of sulphate for this reaction. Being ill may, therefore, in itself make drug metabolism unpredictable.
Related content


Adverse drug reactions during pregnancy
Inpharma, Vol. 1, Iss. 1625, 2008-01 ,pp. :


The cost of adverse drug reactions
By Gautier Sophie Bachelet Hélène Bordet Régis Caron Jacques
Expert Opinion on Pharmacotherapy, Vol. 4, Iss. 3, 2003-03 ,pp. :


Expert Opinion on Drug Safety, Vol. 2, Iss. 4, 2003-07 ,pp. :

